SELL TO SCIENTISTS.

Biopharma

Eli Lilly

Eli Lilly develops medicines across diabetes, obesity, oncology, and neuroscience, including its market-defining incretin therapies. Its Lilly Research Laboratories maintain extensive academic alliances and AI partnerships to expand its pipeline.

$9.0B R&D Spend
Biopharma Industry
460 Academic Collaborations
6,100 Patents

Free to browse · subscribe to unlock the full dataset

See the full dataset.

Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.

Sign Up Free →
Get Started